Filed: 11/13/2024ACC: 0001172661-24-004656
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 29 equity positions with a total reported market value of $339.76M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
29
Positions
$339.76M
Total AUM (reported)
55.59M
Total Shares
Allocation by class
COM$225.62M66.4%
COM NEW$44.24M13.0%
SPONSORED ADS$24.52M7.2%
COMMON STOCK$16.70M4.9%
CLASS A ORD SHS$13.25M3.9%
SPON ADS$10.21M3.0%
CL A ORD SHS$5.22M1.5%
Portfolio Concentration
Top 3$88.08M25.9%
4–10$112.82M33.2%
11–25$128.86M37.9%
Rest$10.00M2.9%
Top 3 weight
25.9%
Top 10 weight
59.1%
Voting Authority Distribution
Total shares with voting rights: 55.59M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
55.59M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole29
Shared0
Other0
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings29
Rows:
NEUROGENE INC
SOLEShares1M
TypeSH
Market value$42.14M
12.40%
Sole
0.00
Shared
1M
None
0.00
ABIVAX SA
SOLEShares2.13M
TypeSH
Market value$24.52M
7.22%
Sole
0.00
Shared
2.13M
None
0.00
PLIANT THERAPEUTICS INC
SOLEShares1.91M
TypeSH
Market value$21.41M
6.30%
Sole
0.00
Shared
1.91M
None
0.00
EVOLUS INC
SOLEShares1.17M
TypeSH
Market value$18.95M
5.58%
Sole
0.00
Shared
1.17M
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares750K
TypeSH
Market value$17.06M
5.02%
Sole
0.00
Shared
750K
None
0.00
ARCELLX INC
SOLEShares200K
TypeSH
Market value$16.70M
4.92%
Sole
0.00
Shared
200K
None
0.00
CYTOKINETICS INC
SOLEShares316K
TypeSH
Market value$16.68M
4.91%
Sole
0.00
Shared
316K
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares1.30M
TypeSH
Market value$15.05M
4.43%
Sole
0.00
Shared
1.30M
None
0.00
DYNAVAX TECHNOLOGIES CORP
SOLEShares1.33M
TypeSH
Market value$14.77M
4.35%
Sole
0.00
Shared
1.33M
None
0.00
CONTEXT THERAPEUTICS INC
SOLEShares6.93M
TypeSH
Market value$13.59M
4.00%
Sole
0.00
Shared
6.93M
None
0.00
ZURA BIO LTD
SOLEShares3.26M
TypeSH
Market value$13.25M
3.90%
Sole
0.00
Shared
3.26M
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares514.66K
TypeSH
Market value$12.61M
3.71%
Sole
0.00
Shared
514.66K
None
0.00
MERUS N V
SOLEShares250K
TypeSH
Market value$12.49M
3.68%
Sole
0.00
Shared
250K
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares1M
TypeSH
Market value$11.94M
3.51%
Sole
0.00
Shared
1M
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares255K
TypeSH
Market value$10.22M
3.01%
Sole
0.00
Shared
255K
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares2.81M
TypeSH
Market value$10.21M
3.00%
Sole
0.00
Shared
2.81M
None
0.00
UROGEN PHARMA LTD
SOLEShares758.79K
TypeSH
Market value$9.64M
2.84%
Sole
0.00
Shared
758.79K
None
0.00
OPTINOSE INC
SOLEShares12.86M
TypeSH
Market value$8.62M
2.54%
Sole
0.00
Shared
12.86M
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares275K
TypeSH
Market value$7.53M
2.22%
Sole
0.00
Shared
275K
None
0.00
OUTLOOK THERAPEUTICS INC
SOLEShares1.29M
TypeSH
Market value$6.90M
2.03%
Sole
0.00
Shared
1.29M
None
0.00
JASPER THERAPEUTICS INC
SOLEShares322.38K
TypeSH
Market value$6.06M
1.78%
Sole
0.00
Shared
322.38K
None
0.00
VOYAGER THERAPEUTICS INC
SOLEShares959.95K
TypeSH
Market value$5.62M
1.65%
Sole
0.00
Shared
959.95K
None
0.00
HELIX ACQUISITION CORP II
SOLEShares500K
TypeSH
Market value$5.22M
1.54%
Sole
0.00
Shared
500K
None
0.00
TSCAN THERAPEUTICS INC
SOLEShares1.02M
TypeSH
Market value$5.06M
1.49%
Sole
0.00
Shared
1.02M
None
0.00
UNICYCIVE THERAPEUTICS INC
SOLEShares8.56M
TypeSH
Market value$3.49M
1.03%
Sole
0.00
Shared
8.56M
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NEUROGENE INCSOLE | COM | 1M | SH | $42.14M 12.40% | 0.00 | 1M | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 2.13M | SH | $24.52M 7.22% | 0.00 | 2.13M | 0.00 |
PLIANT THERAPEUTICS INCSOLE | COM | 1.91M | SH | $21.41M 6.30% | 0.00 | 1.91M | 0.00 |
EVOLUS INCSOLE | COM | 1.17M | SH | $18.95M 5.58% | 0.00 | 1.17M | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 750K | SH | $17.06M 5.02% | 0.00 | 750K | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 200K | SH | $16.70M 4.92% | 0.00 | 200K | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 316K | SH | $16.68M 4.91% | 0.00 | 316K | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 1.30M | SH | $15.05M 4.43% | 0.00 | 1.30M | 0.00 |
DYNAVAX TECHNOLOGIES CORPSOLE | COM NEW | 1.33M | SH | $14.77M 4.35% | 0.00 | 1.33M | 0.00 |
CONTEXT THERAPEUTICS INCSOLE | COM | 6.93M | SH | $13.59M 4.00% | 0.00 | 6.93M | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 3.26M | SH | $13.25M 3.90% | 0.00 | 3.26M | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 514.66K | SH | $12.61M 3.71% | 0.00 | 514.66K | 0.00 |
MERUS N VSOLE | COM | 250K | SH | $12.49M 3.68% | 0.00 | 250K | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 1M | SH | $11.94M 3.51% | 0.00 | 1M | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 255K | SH | $10.22M 3.01% | 0.00 | 255K | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 2.81M | SH | $10.21M 3.00% | 0.00 | 2.81M | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 758.79K | SH | $9.64M 2.84% | 0.00 | 758.79K | 0.00 |
OPTINOSE INCSOLE | COM | 12.86M | SH | $8.62M 2.54% | 0.00 | 12.86M | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 275K | SH | $7.53M 2.22% | 0.00 | 275K | 0.00 |
OUTLOOK THERAPEUTICS INCSOLE | COM | 1.29M | SH | $6.90M 2.03% | 0.00 | 1.29M | 0.00 |
JASPER THERAPEUTICS INCSOLE | COM NEW | 322.38K | SH | $6.06M 1.78% | 0.00 | 322.38K | 0.00 |
VOYAGER THERAPEUTICS INCSOLE | COM | 959.95K | SH | $5.62M 1.65% | 0.00 | 959.95K | 0.00 |
HELIX ACQUISITION CORP IISOLE | CL A ORD SHS | 500K | SH | $5.22M 1.54% | 0.00 | 500K | 0.00 |
TSCAN THERAPEUTICS INCSOLE | COM | 1.02M | SH | $5.06M 1.49% | 0.00 | 1.02M | 0.00 |
UNICYCIVE THERAPEUTICS INCSOLE | COM | 8.56M | SH | $3.49M 1.03% | 0.00 | 8.56M | 0.00 |
Page 1 of 2